Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 116 (RPL21P116)

Target: RPL21P116
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L21 pseudogene 116 (RPL21P116) is a processed pseudogene related to the ribosomal protein L21 gene. It does not encode a functional protein and has no known biological function or disease relevance. Pseudogenes like RPL21P116 arise from duplication or retrotransposition events of protein-coding genes, but accumulate mutations that render them inactive. RPL21P116 is annotated in the human genome, but has no evidence of functional significance or clinical utility[4][5].

Other names: RPL21_55_1456RPL21P116

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 116 (RPL21P116).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 116 (RPL21P116).

Explore the full profile